Author:
Payne Kyle K.,Zoon Christine K.,Wan Wen,Marlar Khin,Keim Rebecca C.,Kenari Mehrab Nasiri,Kazim A. Latif,Bear Harry D.,Manjili Masoud H.
Publisher
Springer Science and Business Media LLC
Reference58 articles.
1. Sotomayor EM, Borrello I, Levitsky HI (1996) Tolerance and cancer: a critical issue in tumor immunology. Crit Rev Oncog 7:433–456
2. Guckel B, Rentzsch C, Nastke MD et al (2006) Pre-existing T-cell immunity against mucin-1 in breast cancer patients and healthy volunteers. J Cancer Res Clin Oncol 132:265–274
3. Goodell V, Waisman J, Salazar LG et al (2008) Level of HER-2/neu protein expression in breast cancer may affect the development of endogenous HER-2/neu-specific immunity. Mol Cancer Ther 7:449–454
4. Rentzsch C, Kayser S, Stumm S et al (2003) Evaluation of pre-existent immunity in patients with primary breast cancer: molecular and cellular assays to quantify antigen-specific T lymphocytes in peripheral blood mononuclear cells. Clin Cancer Res 9:4376–4386
5. Morales JK, Kmieciak M, Knutson KL et al (2010) GM-CSF is one of the main breast tumor-derived soluble factors involved in the differentiation of CD11b-Gr1- bone marrow progenitor cells into myeloid-derived suppressor cells. Breast Cancer Res Treat 123:39–49
Cited by
19 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献